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Introduction 
Carbon nanotubes (CNTs) are rolled-up sheets of hexagonally ordered carbon atoms, giving 
tubes with diameters on the order of a few nanometers and lengths typically in the micron 
range. They may be single- or multi-walled (SWCNTs and MWCNTs respectively), and can 
be electrically conducting or semiconducting depending upon the orientation of the carbon 
lattice with respect to the tube axis (known as chirality in this context). Since the seminal 
report of their synthesis in 1991,1 CNTs have fascinated scientists of all strides. Physicists 
have been intrigued by their electrical, thermal, and vibrational potential. Materials scientists 
worked on integrating them into ultra-strong composites and electronic devices, while 
chemists were fascinated by the effects of rolling on the conventionally planar hexagonal 
carbon lattice and developed new synthesis and purification techniques. Those in the life 
sciences considered how these engineered nanomaterials could bring radically new 
functions to biological systems and applications in medicine. 
Now that the crown of “wonder material” in the public perception is being usurped by 
graphene, it is time to assess the real impact of CNTs. In terms of materials applications the 
results are clear – a bicycle made of a CNT-carbon fibre composite won the Tour de France 
in 2006,2 and in 2013 a computer made from CNT-based transistors was unveiled.3 But what 
is the status of their contribution to biological and medicinal applications? CNTs are certainly 
an enticing prospect in this area: their aspect ratio is thought to be responsible for their 
excellent cell penetration properties; anisotropic conductivity/semi-conductivity along their 
axis is ideal for integration with nervous and muscular tissue; an ultra-high surface area 
maximises their ability to ‘talk’ with biological matter; the hollow interior provides a very large 
cargo-carrying capacity for drug delivery; and their exteriors are readily functionalised to 
permit tailoring of solubility and biological recognition.  
However, to date no large-scale, real-life biotechnological CNT breakthrough has been 
industrially adopted.4 This is to a large extent due to a number of significant hurdles which 
CNTs present for the life sciences. The most significant issue is multiparametric sample 
variability in terms of length, diameter, number of walls, chirality, degree and arrangement of 
functionalization, and topological, graphitic, and residual catalyst impurities. These levels of 
variability can be minimised,5 but not eliminated, and that only with significant sample loss 
and increasing financial burden. CNT polydispersity is not just a problem for repeatable and 
synthesis characterisation, but is also a major barrier to governmental approval of 
medicines, being much more complex than the comparatively well-defined length variation of 
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polymers used in some drug formulations (where a linear polydispersity index of 1.10 may 
be acceptable6) or the range of attachment number in antibody-drug conjugates.7 
Furthermore, while many groups have reported improved cell penetration with using CNTs, 
the exact mechanisms for uptake are still very much a matter of debate.8 Recent toxicity 
studies have corrected some early misapprehensions and indicated that comparatively short 
functionalised CNTs are harmless and cleared easily, although these must be taken with the 
caveat of potential batch variability.9 Bearing these considerations in mind, it is important to 
note that neither of the two current clinical trials involving CNTs have direct contact between 
CNTs and living biological matter, being externally-based diagnostic systems.10 
What then should we make of the investment in 
resource which has been placed into biological 
applications of CNTs? The literature is replete with 
the appendage of CNTs to nearly every biological 
system available, but in the vast majority of cases the 
CNT provides an incremental improvement to an 
existing technology. For example, the fact that CNTs 
produce heat when irradiated with near-IR light means that they could be used for selective 
killing of cancer cells. However gold nanoshells show the same behaviour and are simpler to 
purify, characterise, handle, and process. Similarly, there are many cases of CNTs 
decorated with polymers and/or targeting moieties and associated with therapeutic 
molecules,9, 11 but the primary rationale behind use of CNTs is either due to hydrophobic/π-
stacking encapsulation or exploitation of high aspect ratio, both of which could be achieved 
using other methods. Lastly, there have been reports of in vitro and in vivo biodegradation of 
functionalized CNTs.12 However, the kinetics of the degradative processes may be too slow 
to alleviate the risk from tissue accumulation from repeated, long-term use of CNT as a 
component of a therapeutic agent.        
 Given the challenges of CNTs delineated above, it is proving difficult to justify taking 
these materials forward into the clinic. However, we believe that these challenges are not the 
end of the story, but that they must be outweighed by the genuinely new properties 
introduced by the CNTs: a viable carbon nanotube biotechnology is one in which the unique 
properties of nanotubes bring about an effect that would be otherwise impossible. In this 
Outlook, we therefore seek to reframe the field by highlighting those biological applications in 
which the singular properties of CNTs provide some entirely new activity or biological effect, 
differing by type rather than just degree from existing technologies. We will not feature 
examples which do not fit this description, for which comprehensive reviews can be found 
elsewhere.9, 11 
A viable carbon nanotube 
biotechnology is one in which the 
unique properties of nanotubes 




One-Dimensional Conductivity: Neural Interfaces 
 
Figure 1. (a) Important aspects of CNTs for use in neural interfaces. Illustration of using CNTs to (b) provide electrical input, 
(c) obtain output, and (d) alter neuronal behaviour. 
As one-dimensional wires, CNTs display 
many advantageous properties for use in 
neural interfaces (Fig. 1a). The conductive 
properties of CNTs arise from the conjugated 
π-electron systems which extend over the 
entire structure resulting in either a continuum 
of electron energy levels, giving highly 
conducting CNTs, or a small gap, yielding 
semiconducting CNTs. CNTs also have an 
enormous electrochemically accessible 
surface area, maximising their prospects for 
interface. Their structurally anisotropic 
conductivity has a certain similarity to that of 
neurons. In fact, small CNT bundles have 
dimensions similar to those of dendrites (the 
branched protrusions of neurons), highlighting 
possibilities for integration. CNTs therefore 
can potentially provide a high-resolution 
solution for the readout, repair, or 
reconfiguration of neural networks in the 
central (brain, spinal cord) or peripheral 
nervous system.13 No other technology has 
yet been described to offer such electronic 
control at such small length scales and with 
such control over directionality – metallic 
nanowires are at least an order of magnitude 
wider than the smallest CNT bundles used as 
electrodes, and do not display such 
anisotropy, nor proportional strength and 
rigidity. 
Box 1. CNTs and neural interfaces: key 
points 
What is special about CNTs? Metallic CNTs 
are highly conductive 1D nanowires with a 
singularly high surface area, aspect ratio, 
and tensile strength. 
What is the biological interest? Nature’s 
electrical networks of neurons possess the 
secrets of sense, thought, movement, and 
memory, yet reading or influencing the 
system at cellular resolution is a major 
challenge. 
What has been achieved? Ultrafine wires 
comprised of CNTs provide not only high 
resolution neuronal recording and 
stimulation, but can also induce new types 
of nervous activity and allow electrical cross-
talk between muscle cells. 
What does the future hold? Neuronal 
stimulation can be used to treat epilepsy 
and Parkinsons; being so thin, CNT 
electrodes for this purpose will produce far 
lower levels of inflammation. Further 
interface with muscular and sensory cells 
could help patients recover other functions. 
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Electrical stimulation of the nervous system can attain significant improvement of certain 
symptomatic effects in conditions such as epilepsy and Parkinsons.14 Motivated by this fact, 
CNT fibre electrodes have been created for miniaturisation of both in vivo recording and 
stimulation of mouse brain tissue.15 By making electrodes with a cross-section ten times 
smaller than that of the smallest metallic equivalent, the inflammatory response was 
significantly reduced.  
On a different but related direction, studies by Bellerini et al 16 indicated that growth of 
neurons on surfaces decorated with MWCNTs resulted in a six-fold increase in the 
frequency of spontaneous action potentials, which are indicative of networked cells. Overall 
neuronal growth was not significantly different from samples prepared in the absence of 
CNTs. Although the mechanism for the improvement could not be elucidated, it was thought 
likely that the conductivity of CNTs was responsible. Soon afterwards, Kotov showed that 
neurons could be cultured on a CNT-film, differentiating naturally.17 By applying a current 
laterally across the film, neuronal stimulation was achieved resulting in action potentials with 
a natural electrical current signature, confirming that CNT conductivity was involved (Fig. 
1b). 
Instead of using CNTs for electrical input, Keefer and coworkers used CNTs to output a high 
quality recording of neural activity by coating conventional metal wire electrodes with CNTs 
(Fig. 1c). In order to obtain adequate signal-to-noise ratio, the impedance of the electrode 
must be minimised, which usually requires tip enlargement. This increases the geometric 
surface area and thus reducing spatial resolution. By coating the tip with intrinsically high 
surface area CNTs they were able to increase the electrochemical surface area without 
compromising the overall tip diameter. The higher electrochemically accessible surface area 
was credited with a significant reduction in impedance, and hence higher contrast and time 
resolution in cultured neurons and even in rat motor cortex and primate visual cortex 
models.18 Kotov and co-workers then developed electrodes composed of a layers CNT-
polymer composite which were biocompatible and capable of differentiating biological signal 
of living mouse brains from instrument noise.19 In 2015 Pasquali employed electrodes made 
of wet-spun CNT fibres20 as neural recording probes.15 The fibres had tissue contact 
impedances up to 20 times lower than that of PtIr and 6 times lower than tungsten wire of 
the same size. The lower impedance was attributed to the high ion-accessible surface due to 
interstitial spaces in CNT bundles. After surgical insertion into mouse brains, the fibres were 
more well tolerated than PtIr electrodes, while displaying the same neural recording 
capability. 
Furthermore, Ballerini showed that CNTs could enhance and introduce new functions to 
neurons.21 Rat hippocampal cells were cultured on a CNT film, and in addition to the 
increase in post-synaptic current frequency, they investigated the propensities of CNTs to 
assist in electrically-simulating the regenerative properties of neurons. Regular pulses were 
applied to the neuronal soma (main cell body), forcing action potentials, and somatic after-
depolarisations (ADPs) were recorded. ADPs are indicative of Ca2+ electrogenesis in the 
peripheral dendrites of the cell mediated by potentials flowing in reverse, and require 
communication between the soma and the dendrites. ADPs were far more prevalent in cells 
cultured on CNTs than in those on glass, and the effect was consistent with CNTs acting as 
shortcuts between proximal and distal compartments of the neurons (Fig. 1d). Significantly, 
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neither using indium tin oxide which is highly conductive but smooth, nor insulating self-
assembled peptide nanofibres of similar dimensions to CNTs, were the ADPs observed, 
indicating that the effect was particular to CNTs. 
The next step for this technology is to interface CNTs with other electrically active cells. The 
first steps in this direction have been taken by Khademhosseini who has integrated CNTs 
into a crosslinked gelatin matrix for growth of cardiac muscle cells.22 The resultant network of 
CNTs provides both mechanical strength and electrical conductivity to the material which 
mimics the extracellular matrix of the heart, and in particular is reminiscent of the conducting 
purkinje fibres which facilitate intercellular communication to give synchronous beating. Not 
only did the cells grow more uniformly on the CNT gel compared to the CNT-free analogue, 
but the spontaneous beating was more frequent and could be externally modulated through 
application of an electric field. It was even possible to release portions of the cell/gel film to 
give macroscopic beating bioactuators capable of swimming and pumping.  
Overall, these studies have shown that there is scope for CNTs to be used to control and 
modulate neurons, to which they bear a certain similarity, being elongated and electrically 
active. The results garnered from the research above raise the possibility of using CNTs to 
gain insights into neuronal function. It is likely that through these techniques, the 
understanding of micro- and nanoscale neural phenomena will develop concurrently with the 
creation of CNT materials for neural stimulation and control. While these results are of great 
interest, there is a significant theoretical gap in terms of exactly how neurons and CNTs 
interact which requires further in-depth experimentation, knowledge that will be vital if these 
technologies are to be fully realised. Moving forward, an important goal is the interface of 
CNTs with other electrically active cells such as other forms of cardiac, muscle and sensory 
receptor cells. It can be hoped that such advances will help muscular regeneration and 




Versatile and Robust Encapsulation: Delivery of Undeliverables 
 
Figure 2. Encapsulation in CNTs for biological applications. (a) Beneficial properties of CNTs for encapsulation. (b) Na125I-
containing nanocapsules decorated with glycosyl units, and SPECT images of mice treated with different doses of 
Na125I@CNT and free Na125I showing characteristic biodistribution. Adapted by permission from Macmillan Publishers Ltd: 
Nature Mater.,9, 485-490, copyright 2010. (c) Filling CNTs with HMM and reversible sealing using C60. (d) Filling of nitrogen-
doped CNT cups with paclitaxel, corking with gold nanoparticles, and enzymatic digestion. 
 CNTs are structurally hollow nanofibres, and this structural characteristic makes 
them attractive candidates for delivery of drugs and diagnostic agents (Fig. 2a).23 
Encapsulation of therapeutic agents within nanoscale constructs is a popular strategy for 
controlling biodistribution, ensuring that off-target effects are minimised. In the context of 
imaging, this approach gives maximal contrast. There are two important aspects in which 
CNT inclusion complexes differ from alternative encapsulation methods (e.g. polymer 
micelles, mesoporous silica, etc.). Firstly, the cavity is continuous, empty, and the bulk of 
nanotube’s volume, meaning that anything from elemental metals,24 ionic salts,25 
molecules,26 or nanostructures27 can be included in high yield. This contrasts especially with 
micellar architectures in which the host is a microphase in which the target molecule is 
soluble: with CNTs, the material itself can be encapsulated as a pure phase in itself. 
Secondly, the graphene shell can perfectly separate the core from the exterior environment, 
completely sealing the cargo if the ends are closed. The graphene lattice has been 
described as a perfect ‘nanoballoon’ 28, with prohibitively high energy barriers for 
translocation of atoms.29 To illustrate this power, ionic solids which would be too soluble as 
nanoparticles, can be enclosed irreversibly within sealed CNTs by capillary force-mediated 
filling of CNTs in the melt, after which the ends spontaneously close upon cooling.24, 30 
Although a range of biological applications have been attempted for filled CNTs, only a few 
exploit the potential for sealing the cargo.  
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In collaboration with a number of other 
groups, we sealed radioactive Na125I inside 
SWCNTs to create a targeted imaging agent 
with no leakage of radioisotopes (Fig. 2b).31 
The Na125I@SWCNTs were decorated with 
dendritic N-acetylglucosamine, GlcNAcD 
(known to be important in cellular recognition) 
using dipolar cycloaddition reactions with 
azomethine ylids. The resulting capsules 
were administered to mice and using single-
photon emission computed tomography 
(SPECT), 3D tomograms of the biodistribution 
of Na125I-filled CNTs, and free Na125I were 
compared. While the free Na125I was 
concentrated mainly in the thyroid and in the 
stomach, it was found that the CNT-
encapsulated iodide was found almost 
entirely in the lungs, demonstrating that it was 
possible to override the prevalent uptake 
routes. Furthermore, it was possible to reduce 
the minimum visualisable dosage of radiation 
from 1.8 MBq (using free Na125I) to just 0.2 
MBq. This broke all previous records for 
radionuclide-based imaging, due to the 
intense concentration of iodide within the 
nanotubes and its stable retention.  
 Conversely, instead of protecting the 
organism from the cargo, Bonifazi and co-
workers have used MWCNTs to shield a magnetic mixture of metallic iron and iron carbide 
from biological environments in which it would be unstable.32 The CNTs were functionalised 
with an antibody against the epidermal growth factor receptor (EGFR) which is over-
expressed in cancer cells. The Fe@MWCNTs were then used to magnetically separate 
cancer cells from a mixture of cells, providing a useful analytical tool and demonstrating their 
selectivity. Hyperthermia could then be induced under electromagnetic irradiation resulting in 
the death of only the EGFR-expressing cells. Although magnetic manipulation of biological 
matter using nanoparticles is known,33 this is an elegant demonstration of the partitioning 
power of CNT walls.  
 Covalent sealing of nanotube caps requires vacuum annealing from 800°C,34 limiting 
the number of usable substrates. Lower temperature strategies have therefore been 
proposed to keep material trapped within CNTs. Some report that materials can be stably 
included without additional engineering.26 However, with such structures it is quite probable 
that low levels of leaching are still occurring. Pastorin et al 27a have pioneered a method in 
which nanostructures are used as ‘corks’ to prevent leakage of the encapsulated material 
(Fig. 2c). They initially used C60 fullerenes (which have a high affinity for the CNT interior) to 
stopper CNTs filled with hexamethylmelamine (HMM, an anticancer drug). The HMM was 
Box 2. Filling and sealing CNTs: key points 
What is special about CNTs? The interior of 
CNTs can be filled with large quantities of 
almost any other chemical in its pure form. 
Both robust sealing and reversible corking 
are possible. 
What is the biological interest? Permanent 
sealing can render otherwise incompatible 
substances suitable for biological media. 
Stimulus responsive corking could be used 
to create potent drug delivery vehicles 
which release their cargo only at the desired 
target. 
What has been achieved? Mutual 
protection has been afforded to both 
biological systems and the nanotube cargo 
delivered; targeted capture-release of 
therapeutic molecules has been 
demonstrated up to the level of in vitro 
cellular studies. 
What does the future hold? There is great 
promise for directed delivery of otherwise 
undeliverable therapeutics and imaging 
agents. Rigorous codification of production 
and purification protocols and extensive 
safety tests are required to make these 
approaches suitable for the clinic. 
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then inaccessible until washing with dichloromethane removed the corks and liberated the 
drug. Green took this further by appending amines to the C60, resulting in release in aqueous 
acid, conditions relevant for cancer treatment.35 Pastorin performed the first cell studies on 
corked CNTs using a cis-platin@MWCNT system stoppered with gold nanoparticles, 
however toxicity results showed that slow release still occurred from the supposedly plugged 
tubes.27b  
 A different approach to prevent escape of encapsulated matter has been reported by 
Bianco, Gazeau, and Bégin in which two rounds of magnetic ferrite nanoparticle synthesis 
within MWCNTs are performed, resulting in a ‘jammed’ system from which the nanoparticles 
cannot leave.36 Magnetic manipulation was then used to enhance CNT uptake in ovarian 
cancer cells and move or agitate the cells themselves. A satisfyingly successful strategy has 
now been reported by Star, in which gold nanoparticles are grown on the rim of nitrogen-
doped CNT cups, permitting sealing of drugs such as paclitaxel within (Fig. 2d).37 Because 
of the doping, the CNT cups are highly susceptible to enzymatic oxidative degradation 
(which is known, but slow with pristine CNTs38), permitting their programmed disintegration 
in the presence of myeloperoxidase and hydrogen peroxide. Myeloid-derived suppressor 
cells, responsible for immunosuppressive response in cancer escape, overexpress this 
protein and was found that the paclitaxel payload was efficaciously delivered to these cells, 
promoting their differentiation into dendritic cells and cancelling their immunosuppressive 
character. 
There is enormous scope for further work in this field. An extremely wide selection of 
materials can be sealed in CNTs which could interact with biological matter or imaging 
equipment in a non-contact fashion through the whole spectrum of electromagnetic 
processes. For example, no radionuclides have yet been sealed in CNTs for targeted 
therapy, and the crystalline nature of the cargo has not been exploited at all. Furthermore, 
although some optimisation of corking/uncorking may be required, there is also much 
potential for utilisation of the unique CNT hollow cavity for controlled capture-release under a 
variety of stimuli. In either case, the powerful demonstrations of orthogonalisation between 




Biological Barrier Translocators: from Molecular Transporters to Synthetic 
Membrane Channels 
 
Figure 3. Direct penetration of biological membranes by CNTs. (a) TEM image of ammonium-decorated MWCNTs entering 
HeLa cells.39 (b) Molecular dynamics simulation of short SWCNT forming a membrane channel.40 (c) SEM image of magnetic 
nanotube spearing of MCF-7 cells.41 (d) Confocal fluorescence microscopy image of B-lymphocytes magnetically speared 
with CNTs.42 (e) TEM image of a MWCNT penetrating a microglia cell.43 (f) TEM image of individual MWCNTs passing 
through biological filters in the kidney.44 (g) SEM images of MWCNTs crossing neuronal membranes.45 (h) TEM images of 
ammonium-decorated MWCNTs crossing A549 cell membranes. (i) CNTs acting as membrane pores for translocation of 
DNA.46 
Both experimental and theoretical studies of 
the last ten years have led to the 
understanding that short, surface-modified 
CNTs readily interact with biological 
membranes, other biological barriers and their 
constitutive components. The transport of 
cargo directly across biological membranes 
into the cell cytoplasm without causing 
damage is a major endeavour, as uptake of 
potentially therapeutic moieties is frequently 
restricted to membrane-bound targets. Such 
reported interactions of CNTs with biological 
membranes is a result of a unique 
combination of factors offered by CNTs: a) 
nanoscale fibre shape; b) the amphiphilic 
(hydrophobic-hydrophilic) surface character of 
chemically functionalised CNT; c) their range 
in dimensions (both longitudinal and lateral). 
All of these have led to unexpected and 
somewhat paradoxical observations at the 
back of which CNTs of certain design 
specifications are being developed as 
transporters of biologically active molecules and as artificial ion channels or their blockers. 
The first direct observation of CNTs crossing cell membranes was reported in 2004 by Prato, 
Kostarelos, and Bianco, as part of a study using ammonium-functionalised CNTs as 
Box 3. CNTs and cell membranes: key points 
What is special about CNTs? Nanotubes are 
widely documented directly piercing 
biological membranes, providing intimate 
access to the cell interior. 
What is the biological interest? Cell uptake 
of nanomaterials most commonly occurs 
with the particles incarcerated within an 
inner membrane, thus hindering interaction 
with cellular function. Circumnavigation of 
this route is highly desirable. 
What has been achieved? New methods for 
gene delivery, including a potential 
treatment for stroke.  
What does the future hold? Once the 
specifics and scope of the phenomenon are 
established, we can expect go beyond a host 
of new drug delivery systems, towards 
direct interaction with the cellular interior. 
10 
 
transfection agents for delivery of externally complexed DNA.39 MWCNTs could be seen in 
the process of crossing the membrane in a lengthwise manner (Fig. 3a), precluding an 
endocytotic process being involved. Accordingly, the complexed DNA was expressed in the 
cells. At around the same time, a theoretical study was put forth by Lopez et al in which short 
CNTs with hydrophilic end groups were found to spontaneously interact with lipid 
membranes.40 Interestingly, partial immersion of the tube within the lipid bilayer was 
accompanied by crossing of individual lipid chaperone molecules (Fig. 3b). The study 
highlighted that the surface chemistry of the CNT was central to the behaviour – fully 
hydrophobic CNTs failed to form transmembrane channels. 
Soon afterwards, fine control over delivery of CNTs (and respective cargo) into cells was 
documented by Cai and co-workers. By utilising CNTs which possessed ferromagnetic nickel 
particles at one end, they were able to create “nanotube spears.” By applying a rotating 
magnetic field, a swarm of rapidly moving CNTs was generated which was capable of 
penetrating cell membranes (as observed by SEM, Fig. 3c). By attaching DNA to the CNTs, 
it was possible to transfect a range of mammalian cell lines. Nanotube spearing of B 
lymphocytes was observed using phase contrast and confocal microscopy (Fig. 3d).42 The 
process did not result in activation of the naïve B cells, which is vital for the study of these 
cells which are involved in malignancies and autoimmune diseases. Although in these 
cases, it was found that magnetic manipulation was necessary to achieve delivery of the 
DNA, seemingly in contradiction of the spontaneous direct penetration model, it should be 
noted that far lower concentrations of CNTs were used compared to other studies. 
On the back of these original observations, the use of CNTs for treatment of disease 
conditions relating to the brain started to appear. The blood-brain barrier is a major hurdle for 
medicine, and if the unique penetration properties of CNTs could be harnessed in this area, 
it would be a significant contribution to healthcare. In 2007 it was reported that microglia, 
immune cells of the central nervous system (CNS) spontaneously take up polymer-dispersed 
MWCNTs.43 Microscopy confirmed that direct membrane penetration was taking place (Fig. 
3e), although variation in uptake between cell types suggested that other processes may 
occur concurrently. Impressive in vivo demonstration of the therapeutic potential of CNTs in 
the brain was provided in 2011 by Kostarelos and Pizzorusso.45 Positively charged 
MWCNTs were used to complex siRNA and deliver it to rat brain cells. The RNA used 
interferes with the expression of the Caspase-3 protein which regulates cell death in reaction 
to stroke, leading to neuroprotective effects by preventing its release. The effective delivery 
of siRNA through neuron membranes was evidenced at the molecular level by reduction in 
Caspase-3 production in vitro. After direct injection into the cortex, internalisation of the 
CNTs within neuronal cells was clearly seen using electron microscopy (Fig. 3g). Most 
importantly, functional recovery was shown by improved performance of rats in a “skilled 
reaching” test, following induced stroke. 
The interaction between CNTs and other biological barriers have also been elucidated. The 
appearance of CNTs in the urine of animals treated with the materials is now understood. 
Most nanomaterials are not excreted in this manner because renal clearance requires 
passage through pores in capillary walls (30 nm wide) followed by diffusion through a 
biopolymer matrix (200 – 400 nm long) and emergence between cellular filtration slits (40 nm 
wide). During chemical manipulation, CNTs are commonly collected on synthetic 
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membranes of much larger pores, therefore their passage into the urine was puzzling. 
Microscopy studies revealed that the MWCNTs with diameters of 20-30 nm were capable of 
reorientation in vivo, passing through the pores in a perpendicular manner (Fig. 3f).44 The 
degree of individualisation, shape, and surface character of the CNTs involved are all 
expected to be central to this process. Further insights into the process of membrane binding 
and piercing were reported in a joint experimental-theoretical study in 2013, re-confirming 
that needle-like direct insertion into membranes is possible (Fig. 3h), and indicating that it is 
preceded by a complementary charge-mediated binding step.8b It should be noted that other, 
endocytosis-mediated uptake mechanisms have also been observed.47 
In 2014 an important advance was reported by Geng and co-workers, providing a completely 
new mechanism for delivery through the cell membrane.46 Very short (5-15 nm) lipid-coated, 
open-ended CNTs were shown to insert perpendicularly into lipid vesicles, creating a 
channel analogous to protein pore molecules. Transport of ions, water, and DNA through the 
channel into lipid membrane spheres was shown using single molecule measurements (Fig. 
3i). Analogous measurements performed on live mammalian cells showed the same activity, 
indicating that it is possible to use CNTs to create a pipeline directly into the cell. 
The ability of CNTs to directly cross the threshold between a living cell and its surrounding 
media is potentially a game-changing technology – no other method appears to show the 
same efficacy in bypassing the endosomal route. If it can be shown that they can traverse 
the blood-brain barrier, with a payload in tow, then a huge range of therapeutic possibilities 
await. However, although this direct piercing of membranes has been observed across many 
groups and types of CNT, it remains poorly understood. The ability to predict exactly what 
type of CNT, and with what surface chemistry, will traverse cellular membranes in each 
experiment is urgently needed. Moreover, the ability to create channels directly into cells 
opens up possibilities for direct and programmed communication with the cell interior. 
 
Optical Absorption and Emission, Energy Transfer, and Semi-Conductivity: 
Photobionics 
 
Figure 4. (a) Optical properties of carbon nanotubes: the combination of broadband absorbance, energy transfer, and 
semiconductivity are vital for light harvesting applications, while fluorescent, mechanical and thermal outputs represent 





CNTs exhibit optical absorbance ranging from 
the UV to the far-IR.48 In fact, forests of 
upright CNTs are currently the closest known 
material to a perfect black body absorber.49 
The energy of the absorbed light can be lost 
as heat, emitted as near-IR (NIR) 
fluorescence, or passed on to other species 
through energy transfer processes, meaning 
that CNTs can function as a highly receptive 
part of light harvesting cascades (Fig. 4a).50 
The potentially micron-scale exciton diffusion 
length of CNTs51 makes them ideal for this 
purpose (although caution is required since 
disorder introduced even by non-covalent 
modification can curtail this significantly52). 
For example, encapsulated β-carotene can 
partake in energy transfer,53 and the 
quenching of its photoluminescence by the 
CNT enables otherwise challenging 
vibrational spectroscopy to be performed on 
the molecule.54 Given the growing desire for 
cheap and sustainable energy, the conversion 
of solar radiation into chemical energy is one 
of the present day’s major challenges. 
However, the photosynthetic machinery within plants has been evolutionarily optimised not 
just for light harvesting on the molecular level, but for various aspects of fitness on the 
macroscopic scale, such as competition with other plants by shading.55 Human use of 
photosynthesis is not subject to the same limitations, and would ideally seek to simply 
maximise the energy output, and for this reason there are strong grounds to investigate the 
artificial optimisation of photosynthesis. 
In 2010 Strano and co-workers showed that photosynthetic reaction centres could be 
assembled reversibly into lipidic disks scaffolded along the length of SWCNTs (Fig. 4b). The 
resulting edifices showed a photocurrent which could be turned off upon disassembly.56 
However, although some perturbation of the CNT optical activities was observed, it was not 
conclusively shown that the CNT participated in energy transfer. In 2013, Bertoncini showed 
that light powered bacterial proton pump proteins take part in energy transfer when non-
covalently attached to CNTs, with the mechanism depending on the pH.57  
Strano then took the light harvesting capacity into living system using a plant nanobionics 
approach (Fig. 4c).55 Semiconducting SWCNTs dispersed with charged polymers were 
inserted into extracted chloroplasts, and microscopy revealed that CNTs were localised in 
the chloroplast outer envelope. When infiltrated into plant leaves, the CNTs were again 
localised in the chloroplasts, greatly increasing the absorption bandwidth of their hosts. In 
the isolated chloroplasts, the photosynthetic activity was increased by a factor of three, while 
in leaves the rate of electron transport was also improved. Control experiments with purely 
Box 4. Light harvesting with CNTs: key points 
What is special about CNTs? Nanotubes 
absorb an exceptionally wide spectrum of 
light and can transfer that energy over long 
distances to other species. 
What is the biological interest? Optimising 
and harnessing the light harvesting 
photosynthetic machinery of plants (which 
does not use such a wide range of 
wavelengths) could lead to new 
biotechnological solar energy sources. 
What has been achieved? The 
photosynthetic activity of plants has been 
increased by a factor of three through CNT 
infiltration. 
What does the future hold? The extraction 
of directly usable power from enhanced 
plants would be a major achievement, 
leading to working bionic devices. Non-
medical biotechnologies present a lower 
barrier to actualisation, opening up 
possibilities such as photobionic devices. 
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metallic CNTs gave no rate of improvement, indicating that the effect relied upon exciton 
mobility which occurs in semi-conducting materials.  
The next big advances in this field will require the construction of bionic devices which can 
harness photosynthesis for generation of directly useable power. CNTs may play a major 
role here, both acting as photosensitisers, and energy conduits. As with neuronal interfaces, 
the details of interactions between the CNTs and the biological machinery require further 
study and further elucidation. However, these studies illustrate an important point: CNTs in 
biology can have applications beyond the realm of healthcare. Indeed, the exploitation of the 
life/CNT interface outside of the human body for purposes such as energy generation, waste 
processing, or novel materials, is a perhaps the ideal growth sector for CNT research in the 
short term for two reasons: the finer concerns for medical applications (which may not be 
settled for some time) are less important for energy science; and the interface with other 
non-natural materials is well developed, giving access to physical or chemical outputs. 
Nonetheless, there is also considerable potential for CNTs to interface with other biological 
photosensitive systems such as photoreceptor cells in the retina. 
The optical absorption and energy-transfer properties of nanocarbon can also be used in 
other fields. Carbon nanohorns (tapered CNTs which tend to form spherical aggregates) 
have been used to induce NIR light-controlled muscular actuation in live frogs, through 
generation of reactive oxygen species (ROS) by attached dyes.58 The presence of ROS 
stimulate ion pumps to produce an intracellular calcium flux, leading to a neuronal 
membrane current, and hence nervous signalling. Neither the dyes nor the nanohorns on 
their own resulted in stimulation, showing that the energy transfer process was integral. This 
leading example of remote cellular control opens doors to new tissue therapies and 
photobionic devices. Indeed, within the growing field of optogenetics59 the NIR-activation of 
CNTs could be used much more broadly to influence cellular behaviour. 
The emission properties of CNTs are yielding new opportunities in in vivo imaging systems. 
Animal tissue has substantial transparency in the two windows within the NIR spectral 
region, known as NIR-I (700-900 nm) and NIR-II (1200-1600 nm). Fluorophores with 
absorption and emission energies within these ranges have the potential to provide imaging 
modes with low background interference.60 While there are an abundance of NIR-I 
fluorophores based on small organics, inorganic nanoparticles, and engineered proteins,61 
only CNTs provide fluorescence in the NIR-II region. Furthermore, quenching and decay of 
yield with time is negligible. In this longer-wavelength regime, reduced autofluorescence and 
scattering can provide greater penetration and resolution. The Dai group have developed 
proof-of-concept for this technique by coating SWCNTs with a lipid layer which disperses the 
CNTs in aqueous media without disrupted the side-wall chemistry necessary for 
fluorescence. Images of vasculature in living mice with resolutions of up to 35 µm and 
penetration beyond 2 mm were obtained without the need for prolonged exposure times.62 
However, since full 3D models of blood vessels (and other biological structures) with similar 
penetration, higher resolution, and similarly fast acquisition times can be obtained without 
contrast agents using NIR optical coherence tomography,63 the strength of CNTs in NIR 
imaging lies in their ability to be targeted, and hence highlight otherwise invisible features. 
Using supramolecular decoration of CNTs with M13 viruses, Belcher and coworkers have 
been able to image both bacterial infections64 and submillimetre tumours in mice,65 with 
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subsequent guided surgery in the latter case. The next step for NIR-II imaging using CNTs 
must be to find and develop human-relevant applications in which the few-millimetres of 
penetration can be used to greatest effect. 
Outlook 
The cases discussed above illustrate that truly novel biological effects can be obtained 
through the use of CNTs, while also 
highlighting that such examples are still 
relatively few. Consolidation of effort and 
investment around these unique features and 
the applications that can be developed is 
needed for CNTs to be realised as 
components of widely used products.   
Throughout the discovery and development of the technologies featured in this article, there 
has been considerable interest and discussion around the toxicological profile of CNTs. The 
perceived structural similarity with asbestos fibres seems likely to have been the main 
reason behind the concerns raised.66 There have been numerous studies describing the risk 
of adverse reactions from exposure to CNTs (mainly SWNTs) using both cell and animal 
models and the mechanisms involved.67 Most of this work has focused on the pulmonary 
route of exposure, with an emphasis on the occupational health risks associated with the 
production of nanotube material.68 This important scientific discourse often does not reflect 
the parameters, conditions, material characteristics and levels of exposure that would be 
relevant in the context of a well-designed and highly regulated biomedical application and 
has somewhat unreasonably mired carbon nanotubes with scepticism regarding their safety 
profile. However, during the last 15 years of research in this area, critical conclusions have 
also been reached to indicate that: a) use of short (less than 1 µm long), adequately surface 
functionalized CNTs can alleviate almost entirely most of the risks associated with adverse 
reactions;69 b) defect-rich (e.g. carboxylated)70 or specifically surface-altered71 CNTs can be 
made biodegradable. Importantly, the most recent opinion expressed by the International 
Agency for Research on Cancer (IARC; Lyon, France) following assessment of the potential 
carcinogenicity of carbon nanotubes (among other fiber-shaped materials) confirmed these 
findings.72 Their conclusion was that the lack of coherent evidence across the various 
distinct types of CNTs precluded any (over)generalization. Only the long (13-20 µm long), 
rigid MWCNT-7 (Mitsui & Co.) was classified as possibly carcinogenic to humans (Group 2B 
classification), while SWCNTs and MWCNTs (excluding Mitsui-7 MWCNT) were categorised 
as ‘not classifiable’ as to their carcinogenicity to humans (Group 3 classification). It has to be 
stressed that no human cancer data were available to the IARC working group, indicating an 
inadequate overall body of evidence for the carcinogenicity of CNTs in humans. 
Nevertheless, such conclusive evidence and opinion hopefully will encourage the further 
development of well-designed CNT to utilize the unique properties described in the sections 
above. 
There is enormous scope for exciting research and technology development in this area, as 
long as researchers have a clear idea of what unique benefit they expect to obtain through 
use of CNTs. In many cases this will occur through their combination of different properties, 
as seen above, while some of the more unique properties such as thermal conductivity, the 
This should provide impetus to conceive 
visionary CNT biotechnologies which will 
go beyond the optimisation of established 
strategies to the inception of new levels 
of potency in the biological domain. 
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modulation of the properties of encapsulated species, and photoacoustic mechanical motion, 
remain unexplored in the biological arena. Conversely, there are areas of biology in which 
CNTs have not yet been employed to bring unique function, but could be useful, such as 
interface with biochemical reaction cascades, and cellular signalling and recognition. It is our 
opinion, especially for healthcare applications, that unless CNTs impart a unique property to 
the system, the challenges of multi-parametric polydispersity, and the cost of synthesis and 
purification will ultimately prove resultant technologies to be practically inexpedient. This 
should not discourage workers in the field, but rather provide impetus to conceive visionary 
CNT biotechnologies which will go beyond the optimisation of established strategies to the 
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Carbon nanotubes display a huge variety of unique properties potentially valuable in biology, yet few 
are close to realisation. We assess the potential for nanotubes to yield unprecedented new 
applications through interface with life. 
 
